Patents by Inventor Mark C. Brister

Mark C. Brister has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260115028
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: May 3, 2024
    Publication date: April 30, 2026
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Publication number: 20260069843
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: November 17, 2025
    Publication date: March 12, 2026
    Inventors: Mark C. Brister, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Amy D.L. VandenBerg, Antonio C. Llevares, Daniel Proctor
  • Publication number: 20260047773
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of tracking and locating the same are provided.
    Type: Application
    Filed: July 8, 2025
    Publication date: February 19, 2026
    Inventors: Federico CALZI, Sheldon NELSON, Mark C. BRISTER
  • Publication number: 20260033970
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: July 7, 2025
    Publication date: February 5, 2026
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 12514464
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of tracking and locating the same are provided.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: January 6, 2026
    Assignee: RESHAPE LIFESCIENCES INC.
    Inventors: Federico Calzi, Sheldon Nelson, Mark C. Brister
  • Patent number: 12440358
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: October 10, 2023
    Date of Patent: October 14, 2025
    Assignee: RESHAPE LIFESCIENCES INC.
    Inventors: Mark C. Brister, Neil R. Drake, Daniel J. Proctor, Madeline Campbell
  • Patent number: 12433485
    Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: October 7, 2025
    Assignee: Dexcom, Inc.
    Inventors: Peter C. Simpson, Robert J. Boock, Mark C. Brister, Monica A. Rixman Swinney, Kum Ming Woo, Lisa Nguyen, Seth R. Brunner, Arthur Chee, Melissa A. Nicholas, Matthew D. Wightlin, Jack Pryor, Dubravka Markovic
  • Publication number: 20250235338
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Application
    Filed: August 28, 2024
    Publication date: July 24, 2025
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D.L. VandenBerg
  • Publication number: 20250228684
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Application
    Filed: August 28, 2024
    Publication date: July 17, 2025
    Inventors: Mark C. BRISTER, Kaushik R. PATEL, Andrew P. RASDAL, Nelson QUINTANA, Neil R. DRAKE, Antonio C. LIEVARES, Dubravka MARKOVIC, Amy D.L. VandenBerg
  • Patent number: 12350179
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: August 31, 2023
    Date of Patent: July 8, 2025
    Assignee: RESHAPE LIFESCIENCES INC.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Publication number: 20250107728
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: October 2, 2023
    Publication date: April 3, 2025
    Inventors: Mark C. Brister, Steve Masterson, John Dobbles, Michael Robert Mensinger, Sean T. Saint, Apurv U. Kamath
  • Publication number: 20250032006
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: July 30, 2024
    Publication date: January 30, 2025
    Inventors: Mark C. Brister, James Patrick Thrower, Paul V. Goode, JR.
  • Publication number: 20240382093
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: May 9, 2024
    Publication date: November 21, 2024
    Inventors: Mark C. Brister, Jack Pryor, John Nolting, Jacob S. Leach, Luis Pestana, Nelson Quintana, Vance Swanson, Paul V. Goode, JR., James Patrick Thrower
  • Publication number: 20240324877
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: March 1, 2024
    Publication date: October 3, 2024
    Inventors: Mark C. Brister, Paul V. Neale, Peter C Simpson, James H. Brauker, James Patrick Thrower, Mark Shults, Rathbun Rhodes, Paul V. Goode, JR., Arnold Holmquist
  • Patent number: 12102410
    Abstract: An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.
    Type: Grant
    Filed: October 28, 2020
    Date of Patent: October 1, 2024
    Assignee: DEXCOM, INC
    Inventors: Mark C. Brister, Nelson Quintana, Antonio C. Llevares, John Michael Dobbles, Richard C. Yang, Michael Robert Mensinger
  • Patent number: 12102547
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: October 1, 2024
    Assignee: RESHAPE LIFESCIENCES INC.
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D. L. VandenBerg
  • Publication number: 20240315860
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: October 10, 2023
    Publication date: September 26, 2024
    Inventors: Mark C. BRISTER, Neil R. DRAKE, Daniel J. PROCTOR, Madeline CAMPBELL
  • Patent number: 12090075
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Grant
    Filed: January 10, 2022
    Date of Patent: September 17, 2024
    Assignee: Reshape Lifesciences Inc.
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D. L. VandenBerg
  • Publication number: 20240225487
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: September 26, 2023
    Publication date: July 11, 2024
    Inventors: Mark C. Brister, Steve Masterson, J. Michael Dobbles, Michael Robert Mensinger, Sean T Saint, Apurv U Kamath, James H Brauker, James Patrick Thrower
  • Patent number: 12016648
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: June 25, 2024
    Assignee: Dexcom, Inc.
    Inventors: Mark C. Brister, Jack Pryor, John Nolting, Jacob S. Leach, Luis Pestana, Nelson Quintana, Vance Swanson, Paul V. Goode, Jr., James Patrick Thrower